Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Richards, Frank O ^a  

^a CARTER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE; PRAZIQUANTEL; ANTIMALARIAL AGENT;

HEALTH CARE DELIVERY; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; INFECTION CONTROL; INSECTICIDE TREATED NET; INTEGRATED HEALTH CARE SYSTEM; LYMPHATIC FILARIASIS; MALARIA; MALARIA CONTROL; ONCHOCERCIASIS; REVIEW; SCABIES; SCHISTOSOMIASIS; STRONGYLOIDIASIS; TRACHOMA; TROPICAL DISEASE; MASS DRUG ADMINISTRATION; NEGLECTED DISEASE; TROPICAL MEDICINE;

ANTIMALARIALS; HUMANS; IVERMECTIN; MALARIA; MASS DRUG ADMINISTRATION; NEGLECTED DISEASES; TROPICAL MEDICINE;

EID: 85018564397     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1830-z     Document Type: Review

References (19)

1. The Nobel Assembly at Karolinska Institutet: The 2015 Nobel Prize in Physiology or Medicine (William C. Campbell, Satoshi Omura, Youyou Tu)- Press Release. Nobelprize.org. Nobel Media AB 2014. Web. https://www.nobelprize.org/nobel-prizes/medicine/laureates/2015/press.html. Accessed April 2017.
2. World Health Organization. African Programme for Onchocerciasis Control: progress report, 2014-2015. Wkly Epidemiol Rec. 2015;90:661-74.
3. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec. 2016;91:441-56.
4. World Health Organization. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala. Wkly Epidemiol Rec. 2016;91:501-5.
5. World Health Organization. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions. A manual for health professionals and programme managers. http://apps.who.int/iris/bitstream/10665/43545/1/9241547103-eng.pdf. Accessed Apr 2017.
6. World Health Organization. Ensuring the timely supply and management of medicines for preventive chemotherapy against neglected tropical diseases. Wkly Epidemiol Rec. 2017;92:155-64.
7. Richards F, Boatin B, Sauerbrey M, Sékétéli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 2001;17:558-63.
8. Richards F, Klein RE, León O, Mendizábal-Cabrera R, Lucía Morales A, Cama V, et al. A knowledge, attitudes and practices survey conducted three years after halting ivermectin mass treatment for onchocerciasis in Guatemala. PLoS Negl Trop Dis. 2016;10:e0004777.
9. Hopkins DR, Eigege A, Miri ES, Gontor I, Ogah G, Umaru J, et al. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. Am J Trop Med Hyg. 2002;67:266-72.
10. Evans D, Unnasch T, Richards F. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time. Lancet. 2015;385:2151-2.
11. Blackburn B, Eigege A, Miri E, Mathieu E, Richards F. Successful integration of insecticide-treated bednet distribution and mass drug administration in Central Nigeria. Am J Trop Med Hyg. 2006;75:650-5.
12. Alout H, Krajacich BJ, Meyers JI, Grubaugh ND, Brackney DE, Kobylinski KC, et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J. 2014;13:417.
13. Kobylinski KC, Alout H, Foy BD, Clements A, Adisakwattana P, Swierczewski BE, et al. Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control. Am J Trop Med Hyg. 2014;91:655-62.
14. Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of Bancroftian Filariasis. Clin Infect Dis. 2016;62:334-40.
15. Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, et al. Establishment of the ivermectin research for malaria elimination network: updating the research agenda. Malar J. 2015;14:243.
16. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350:18-22.
17. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies control in a population with endemic disease. New Eng J Med. 2015;373:2305-13.
18. Anselmi M, Buonfrate D, Guevara Espinoza A, Prandi R, Marquez M, Gobbo M, et al. Mass administration of ivermectin for the elimination of onchocerciasis significantly reduced and maintained low the prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador. PLoS Negl Trop Dis. 2015;9:e0004150.
19. Mectizan Donation Program. http://www.merck.com/about/featured-stories/mectizan.html. Accessed April 2017.